178 related articles for article (PubMed ID: 3116371)
21. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
Liew FY; Millott S; Li Y; Lelchuk R; Chan WL; Ziltener H
Eur J Immunol; 1989 Jul; 19(7):1227-32. PubMed ID: 2503386
[TBL] [Abstract][Full Text] [Related]
22. Intracellular activation of human and rodent macrophages by human lymphokines encapsulated in liposomes.
Kleinerman ES; Fogler WE; Fidler IJ
J Leukoc Biol; 1985 May; 37(5):571-84. PubMed ID: 3920339
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
24. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD
J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606
[TBL] [Abstract][Full Text] [Related]
25. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
26. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
27. Preparation and antitumor effect of macrophage activating factor (MAF) encapsulated in liposomes bearing a monoclonal anti-human melanoma (A375) antibody.
Watanabe Y; Uchida E; Higuchi M; Imai Y; Osawa T
J Biol Response Mod; 1987 Oct; 6(5):556-68. PubMed ID: 3316511
[TBL] [Abstract][Full Text] [Related]
28. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA
J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982
[TBL] [Abstract][Full Text] [Related]
29. Characterization and partial purification of a non-interferon macrophage activating factor produced by human leukemic T cell line.
Kutsukake H; Imai K; Harada T; Morikawa S; Tanaka A
J Biochem; 1988 Apr; 103(4):661-6. PubMed ID: 3049565
[TBL] [Abstract][Full Text] [Related]
30. Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon.
Kleinerman ES; Wiltrout RH; Zicht R; Fidler IJ
Cancer Immunol Immunother; 1985; 20(2):151-7. PubMed ID: 3930068
[TBL] [Abstract][Full Text] [Related]
31. Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gamma.
Sanders KM; Littman BH
J Immunol; 1986 Aug; 137(3):876-9. PubMed ID: 3088114
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
Schreiber RD; Hicks LJ; Celada A; Buchmeier NA; Gray PW
J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
[TBL] [Abstract][Full Text] [Related]
33. Partial purification of a macrophage-activating factor for glucose consumption (MAF-G) produced by a human T-cell hybridoma and its relation to a growth-promoting factor.
Osada H; Furukawa-Nakanishi K; Miyamoto D; Kobayashi Y; Osawa T
Lymphokine Res; 1989; 8(4):393-405. PubMed ID: 2509820
[TBL] [Abstract][Full Text] [Related]
34. Establishment of murine macrophage hybridoma clones capable of acquiring tumoricidal activity upon activation with recombinant interferon-gamma and lipopolysaccharide.
Kiyotaki C; Katagiri T; Tatsumi Y; Fujiwara H; Hamaoka T
J Cancer Res Clin Oncol; 1987; 113(4):383-6. PubMed ID: 3110175
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the identity of murine gamma interferon and macrophage activating factor.
Roberts WK; Vasil A
J Interferon Res; 1982; 2(4):519-32. PubMed ID: 6815284
[TBL] [Abstract][Full Text] [Related]
36. Macrophage activation factor from EL-4, a murine T-cell line: antigenic characterization by hamster monoclonal antibodies to murine interferon-gamma.
Meltzer MS; Gilbreath MJ; Crawford RM; Schreiber RD; Nacy CA
Cell Immunol; 1987 Jul; 107(2):340-7. PubMed ID: 3109744
[TBL] [Abstract][Full Text] [Related]
37. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
Talmadge KW; Gallati H; Sinigaglia F; Walz A; Garotta G
Eur J Immunol; 1986 Dec; 16(12):1471-7. PubMed ID: 3102242
[TBL] [Abstract][Full Text] [Related]
38. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray HW; Spitalny GL; Nathan CF
J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
[TBL] [Abstract][Full Text] [Related]
39. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
40. Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset.
Nakajima H; Izumi Y; Sugihara S; Satoh Y; Isumi S; Gotoh T; Fujiwara H; Hamaoka T
Cancer Immunol Immunother; 1987; 25(3):201-8. PubMed ID: 3119213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
